Abstract
This study is aimed at exploring the utility of thermoanalytical methods in the characterization of various polymorphs and solvates of nevirapine. The different forms obtained by recrystallization of nevirapine from various solvents showed morphological differences in SEM. The presence of polymorphic forms is suggested by single sharp melting endotherm different from original sample in DSC and no mass loss in TG, while appearance of desolvation peak in TG indicated the formation of solvates. The higher desolvation temperatures of all the solvates than their respective boiling point indicate tighter binding of solvent. The changes in the crystal lattice were demonstrated by X-ray powder diffraction studies. The enthalpy of fusion rule indicated the existence of monotropy in polymorphic pairs I/O and II/O, while I/II is enantiotropically related. The enthalpy of solution, an indirect measure of the lattice energy of a solid, was well correlated with the crystallinity of all the solid forms obtained. The magnitude of ΔH sol was found to be −14.26 kJ mol−1 for Form V and −8.29 kJ mol−1 for Form O, exhibiting maximum ease of molecular release from the lattice in Form V. The transition temperature was found to be higher than the melting of both the forms except for polymorphic pair I/II providing complementary evidence for the existence of monotropy as well as enantiotropy in these polymorphic pairs.
Similar content being viewed by others
References
Othman A, Evans JSO, Evans IR, Harris RK. Structural study of polymorphs and solvates of finasteride. J Pharm Sci. 2007;96:1380–97.
Kawakami K. Reversibility of enantiotropically related polymorphic transformations from a practical viewpoint: thermal analysis of kinetically reversible/irreversible polymorphic transformations. J Pharm Sci. 2007;96:982–9.
Hilfiker R, Blatter F, Raumer MV. Relevance of solid-state properties for pharmaceutical products. In: Hilfiker R, editor. Polymorphism: in the pharmaceutical industry. Weinheim: Wiley-VCH Verlag GmbH & Co., KGaA; 2006. p. 1–19.
Rustichellia G, Gamberini V, Feriolia MC, Gamberinia R, Ficarra B, Tommasinic S. Solid state study of polymorphic drug: carbamazepine. J Pharm Biomed Anal. 2000;23:41–54.
Van Tonder EC, Mahlatji MD, Malan SF, Liebenberg W, Caira MR, Song M, de Villiers MM. Preparation and physicochemical characterization of 5 niclosamide solvates and 1 hemisolvate. AAPS PharmSciTech. 2004;5(1):1–10. Article 12.
Chadha R, Arora P, Kaur R, Saini A, Singla ML, Jain DVS. Characterization of solvatomorphs of methotrexate using thermoanalytical and other techniques. Acta Pharm. 2009;59:245–7.
Urakami K. Characterization of pharmaceutical polymorphs by isothermal calorimetry. Curr Pharm Biotechnol. 2005;6:193–203.
Chadha R, Arora P, Gupta S, Jain DVS. Complexation of nevirapine with β-cyclodextrins in the presence and absence of Tween 80: characterization, thermodynamic parameters and permeability flux. J Therm Anal Calorim. 2011;105(3):1049–59.
Babra RS, Christopher PP, Adivaraha J, Adam JM, Nair RH. General principles of pharmaceutical solid polymorphism: a supramolecular perspective. Adv Drug Deliv Rev. 2004;56:241–74.
Reguri BR, Chakka R. Crystalline forms of nevirapine. United States Patent 0183738 A1 (2006). Accessed 17 Aug 2006.
Reguri BR, Chakka R. Novel crystalline forms of 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one (Nevirapine). United States Patent 0059653A1 (2005). Accessed 17 March 2005.
Pereira BG, Fonte-Boa FD, Resende JALC, Pinheiro CB, Fernandes NG, Yoshida MI. Pseudopolymorphs and intrinsic dissolution of nevirapine. Cryst Growth Des. 2007;7:2016–23.
Sarkar M, Perumal OP, Panchagnula R. Solid-state characterization of nevirapine. Int J Pharm. 2008;70:619–30.
Caira MR, Stieger N, Liebenberg W, De Villiers MM, Samsodien H. Solvent inclusion by the anti-HIV drug nevirapine: X-ray structures and thermal decomposition of representative solvates. Cryst Growth Des. 2008;8:17–23.
Chadha R, Arora P, Saini A, Jain DVS. Solvated crystalline forms of nevirapine: thermoanalytical and spectroscopic studies. AAPS PharmSciTech. 2010;11:1328–39.
de Oliveira GGG, Ferraz HG, Severino P, Souto EB. Solid dosage forms for active antiretroviral therapy (HAART): dissolution profile study of nevirapine by experimental factorial design. Pharm Dev Technol. 2012. doi:10.3109/10837450.2012.680597
da Silva CCP, Cuffini SL, Faudone SN, Ayala AP, Ellena J. Low-temperature study of a new nevirapine pseudopolymorph. Acta Cryst Sect E. 2008;E64:o292.
Stieger N, Liebenberg W, Wessels JC, Samsodien H, Caira MR. Channel inclusion of primary alcohols in isostructural solvates of the antiretroviral nevirapine: an X-ray and thermal analysis study. Struct Chem. 2010;21(4):771–7.
de Oliveira GGG, Ferraz HG, Severino P, Souto EB. Analysis of phase transition and dehydration processes of nevirapine. J Therm Anal Calorim. 2012;108:53–7.
Acknowledgements
The financial support provided by Department of Science and Technology (DST) and Council for Scientific and Industrial Research (CSIR), New Delhi, India is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chadha, R., Arora, P., Garg, M. et al. Thermoanalytical and spectroscopic studies on different crystal forms of nevirapine. J Therm Anal Calorim 111, 2133–2142 (2013). https://doi.org/10.1007/s10973-012-2666-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10973-012-2666-y